NI201000103A - Formas cristalinas de dimetoxi docetaxel y metodo para preparar el mismo. - Google Patents
Formas cristalinas de dimetoxi docetaxel y metodo para preparar el mismo.Info
- Publication number
- NI201000103A NI201000103A NI201000103A NI201000103A NI201000103A NI 201000103 A NI201000103 A NI 201000103A NI 201000103 A NI201000103 A NI 201000103A NI 201000103 A NI201000103 A NI 201000103A NI 201000103 A NI201000103 A NI 201000103A
- Authority
- NI
- Nicaragua
- Prior art keywords
- docetaxel
- dimetoxi
- prepare
- same
- crystalline forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Formas anhidras, solvatos y hetero-solvatos etanólico, hidratos de dimetoxi-docetaxel o (2R,3S) - 3 - terc - butoxicarbonilamino - 2 - hidroxi - 3 - fenil - propionato de 4 - acetoxi - 2 alfa - benzoiloxi - 5Beta, 20 - epoxi - 1 - hidroxi - 7 Beta, 10Beta - dimetoxi - 9 - oxo - tax - 11 - en - 13alfa - ilo y su expresión.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0800243A FR2926551A1 (fr) | 2008-01-17 | 2008-01-17 | Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
NI201000103A true NI201000103A (es) | 2011-04-26 |
Family
ID=39712334
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NI2010001033A NI201001033A (es) | 2008-01-17 | 2010-06-15 | Formas cristalinas de dimetoxi docetaxel y metodo para preparar el mismo. |
NI2010001032A NI201001032A (es) | 2008-01-17 | 2010-06-15 | Formas crsitalinas de dimetoxi docetaxel y metodo para preparar el mismo. |
NI2010001031A NI201001031A (es) | 2008-01-17 | 2010-06-15 | Formas cristalinas de dimetoxi docetaxel y metodo para preparar el mismo. |
NI201000103A NI201000103A (es) | 2008-01-17 | 2010-06-15 | Formas cristalinas de dimetoxi docetaxel y metodo para preparar el mismo. |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NI2010001033A NI201001033A (es) | 2008-01-17 | 2010-06-15 | Formas cristalinas de dimetoxi docetaxel y metodo para preparar el mismo. |
NI2010001032A NI201001032A (es) | 2008-01-17 | 2010-06-15 | Formas crsitalinas de dimetoxi docetaxel y metodo para preparar el mismo. |
NI2010001031A NI201001031A (es) | 2008-01-17 | 2010-06-15 | Formas cristalinas de dimetoxi docetaxel y metodo para preparar el mismo. |
Country Status (42)
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY164086A (en) | 2009-10-29 | 2017-11-30 | Aventis Pharma Sa | Novel antitumoral use of cabazitaxel |
KR20140018917A (ko) * | 2011-04-12 | 2014-02-13 | 플러스 케미칼스, 에스.에이. | 카바지탁셀의 고상 형태 및 이의 제조 방법 |
TWI526437B (zh) * | 2011-09-09 | 2016-03-21 | 台灣神隆股份有限公司 | 卡巴他賽之結晶型 |
CN104039771B (zh) | 2011-09-26 | 2017-10-27 | Kabi费森尤斯肿瘤学有限公司 | 包括c(7)‑oh和c(13)‑oh甲硅烷基化或仅c(7)‑oh甲硅烷基化的用于制备卡巴他赛的方法 |
CN102503913B (zh) * | 2011-10-20 | 2014-03-26 | 江苏红豆杉生物科技股份有限公司 | 直接用于x射线单晶衍射分析的二甲氧基紫杉烷类化合物单晶晶体的制备方法 |
WO2013065070A1 (en) | 2011-11-01 | 2013-05-10 | Fresenius Kabi Encology Ltd. | Amorphous form of cabazitaxel and process for its preparation |
EP2785701B1 (en) * | 2011-11-28 | 2019-01-02 | Fresenius Kabi Oncology Limited | Crystalline form of carbazitaxel and process for preparation thereof |
JP6025861B2 (ja) | 2011-12-13 | 2016-11-16 | アベンティス・ファーマ・ソシエテ・アノニム | カバジタキセルの結晶形およびこれを調製するための方法 |
WO2013111157A1 (en) * | 2012-01-03 | 2013-08-01 | Shilpa Medicare Limited | Process for preparing amorphous cabazitaxel |
CN104220431A (zh) * | 2012-03-08 | 2014-12-17 | 伊瓦克斯国际有限责任公司 | 卡巴他赛的固态形式及其制备方法 |
CN102675257B (zh) * | 2012-05-10 | 2014-07-02 | 上海金和生物技术有限公司 | 一种卡巴他赛晶体及其制备方法 |
CN102746258B (zh) * | 2012-07-25 | 2015-02-04 | 重庆泰濠制药有限公司 | 卡巴他赛的结晶形式及其制备方法 |
WO2014022237A1 (en) | 2012-07-31 | 2014-02-06 | Yung Shin Pharm. Ind. Co., Ltd. | Amorphous cabazitaxel |
EP2884963B1 (en) | 2012-08-15 | 2017-12-27 | Yung Shin Pharm. Ind. Co. Ltd. | Stable pharmaceutical formulation of cabazitaxel |
CN103664836B (zh) * | 2012-09-20 | 2016-04-20 | 齐鲁制药有限公司 | 7β,10β-二甲氧基多西紫杉醇氘代丙酮合物的晶型A及其制备方法 |
CN102898406B (zh) * | 2012-11-02 | 2014-12-03 | 上海金和生物技术有限公司 | 一种卡巴他赛晶体及其制备方法 |
CN103058960B (zh) * | 2012-12-12 | 2014-12-10 | 江苏奥赛康药业股份有限公司 | 卡巴他赛多晶型形式及其制备方法 |
EP2743264A1 (en) | 2012-12-13 | 2014-06-18 | INDENA S.p.A. | New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof |
KR101429543B1 (ko) * | 2012-12-13 | 2014-08-14 | 주식회사 삼양바이오팜 | 카바지탁셀의 신규 결정형 및 그 제조방법 |
CN103910698B (zh) * | 2012-12-30 | 2016-01-20 | 上海医药工业研究院 | 卡巴他赛丙酮合物及其结晶 |
CN103910696B (zh) * | 2012-12-30 | 2016-01-20 | 上海医药工业研究院 | 卡巴他赛异丙醚合物及其结晶 |
CN103910697B (zh) * | 2012-12-30 | 2016-08-03 | 上海医药工业研究院 | 卡巴他赛乙酸合物及其结晶 |
AU2013368947B2 (en) * | 2012-12-31 | 2016-11-24 | Shilpa Medicare Limited | Process for preparing amorphous Cabazitaxel |
WO2014115168A2 (en) * | 2013-01-23 | 2014-07-31 | Leiutis Pharmaceuticals Private Limited | Novel solvate forms of cabazitaxel and process for preparation thereof |
WO2014128728A2 (en) * | 2013-02-25 | 2014-08-28 | Laurus Labs Private Limited | Solid forms of cabazitaxel and processes for preparation thereof |
EP2815749A1 (en) | 2013-06-20 | 2014-12-24 | IP Gesellschaft für Management mbH | Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern |
WO2015000165A1 (zh) * | 2013-07-04 | 2015-01-08 | 北京新天宇科技开发有限公司 | 二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法 |
CN103450119B (zh) * | 2013-09-24 | 2015-06-17 | 天津炜捷制药有限公司 | 一种卡巴他赛晶型w及其制备方法 |
EP2865675A1 (en) * | 2013-10-23 | 2015-04-29 | INDENA S.p.A. | A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof |
EP2865674A1 (en) | 2013-10-23 | 2015-04-29 | INDENA S.p.A. | Crystalline solvate forms of Cabazitaxel |
CN103601704B (zh) * | 2013-11-22 | 2015-05-06 | 石家庄智恒医药科技有限公司 | 无定形卡巴他赛的制备 |
CN104945453B (zh) * | 2014-03-28 | 2018-06-26 | 江苏天士力帝益药业有限公司 | 吡唑衍生物的多晶型物 |
US10188626B2 (en) | 2015-11-03 | 2019-01-29 | Cipla Limited | Stabilized cabazitaxel formulations |
WO2020249507A1 (en) | 2019-06-11 | 2020-12-17 | Indena S.P.A. | Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2163837C (en) * | 1994-12-13 | 1999-07-20 | Robert K. Perrone | Crystalline paclitaxel hydrates |
US5847170A (en) * | 1995-03-27 | 1998-12-08 | Rhone-Poulenc Rorer, S.A. | Taxoids, their preparation and pharmaceutical compositions containing them |
MA23823A1 (fr) * | 1995-03-27 | 1996-10-01 | Aventis Pharma Sa | Nouveaux taxoides, leur preparation et les compositions qui les contiennent |
FR2745814B1 (fr) * | 1996-03-06 | 1998-04-03 | Rhone Poulenc Rorer Sa | Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent |
FR2771092B1 (fr) * | 1997-11-18 | 1999-12-17 | Rhone Poulenc Rorer Sa | Procede de preparation de derives de la classe des taxoides |
US6346543B1 (en) * | 1998-08-17 | 2002-02-12 | Aventis Pharma S.A. | Use of a taxoid to treat abnormal cell proliferation in the brain |
AU2002365883A1 (en) * | 2001-11-30 | 2003-06-17 | Bristol-Myers Squibb Company | Paclitaxel solvates |
FR2859996B1 (fr) * | 2003-09-19 | 2006-02-03 | Aventis Pharma Sa | Solvat acetonique du dimethoxy docetaxel et son procede de preparation |
US20070142457A1 (en) * | 2005-10-12 | 2007-06-21 | Alessandro Pontiroli | Crystalline forms of docetaxel and processes for their preparation |
TWI394765B (zh) * | 2008-12-12 | 2013-05-01 | Ind Tech Res Inst | 難燃水性聚胺基甲酸酯分散液 |
MY164086A (en) | 2009-10-29 | 2017-11-30 | Aventis Pharma Sa | Novel antitumoral use of cabazitaxel |
TWI526437B (zh) | 2011-09-09 | 2016-03-21 | 台灣神隆股份有限公司 | 卡巴他賽之結晶型 |
EP2785701B1 (en) | 2011-11-28 | 2019-01-02 | Fresenius Kabi Oncology Limited | Crystalline form of carbazitaxel and process for preparation thereof |
JP6025861B2 (ja) | 2011-12-13 | 2016-11-16 | アベンティス・ファーマ・ソシエテ・アノニム | カバジタキセルの結晶形およびこれを調製するための方法 |
-
2008
- 2008-01-17 FR FR0800243A patent/FR2926551A1/fr not_active Withdrawn
-
2009
- 2009-01-15 KR KR1020107015939A patent/KR20100103614A/ko not_active Application Discontinuation
- 2009-01-15 ME MEP-2016-280A patent/ME02694B/me unknown
- 2009-01-15 NZ NZ603797A patent/NZ603797A/xx not_active IP Right Cessation
- 2009-01-15 CA CA2712373A patent/CA2712373C/fr not_active Expired - Fee Related
- 2009-01-15 JP JP2010542661A patent/JP5932219B2/ja active Active
- 2009-01-15 SG SG2012015962A patent/SG179446A1/en unknown
- 2009-01-15 AU AU2009227081A patent/AU2009227081B2/en not_active Ceased
- 2009-01-15 NZ NZ598289A patent/NZ598289A/xx not_active IP Right Cessation
- 2009-01-15 SI SI200931571A patent/SI2247582T1/sl unknown
- 2009-01-15 CN CN201410257561.XA patent/CN104130220A/zh active Pending
- 2009-01-15 NZ NZ586829A patent/NZ586829A/en not_active IP Right Cessation
- 2009-01-15 PL PL09722321T patent/PL2247582T3/pl unknown
- 2009-01-15 DK DK09722321.8T patent/DK2247582T3/da active
- 2009-01-15 EA EA201070856A patent/EA017670B1/ru not_active IP Right Cessation
- 2009-01-15 PT PT97223218T patent/PT2247582T/pt unknown
- 2009-01-15 ES ES09722321.8T patent/ES2606228T3/es active Active
- 2009-01-15 RS RS20161064A patent/RS55519B1/sr unknown
- 2009-01-15 ME MEP-2010-114A patent/ME01009B/me unknown
- 2009-01-15 UA UAA201010129A patent/UA105896C2/uk unknown
- 2009-01-15 AR ARP090100119A patent/AR070175A1/es not_active Application Discontinuation
- 2009-01-15 CN CN200980102389.8A patent/CN101918385B/zh not_active Expired - Fee Related
- 2009-01-15 KR KR20157008523A patent/KR20150042302A/ko not_active Application Discontinuation
- 2009-01-15 LT LTEP09722321.8T patent/LT2247582T/lt unknown
- 2009-01-15 WO PCT/FR2009/000042 patent/WO2009115655A2/fr active Application Filing
- 2009-01-15 EP EP09722321.8A patent/EP2247582B1/fr active Active
- 2009-01-15 HU HUE09722321A patent/HUE032150T2/en unknown
- 2009-01-15 MX MX2010007840A patent/MX2010007840A/es active IP Right Grant
- 2009-01-15 BR BRPI0906518-0A patent/BRPI0906518A2/pt not_active Application Discontinuation
- 2009-01-15 CN CN201410258534.4A patent/CN104130221A/zh active Pending
- 2009-01-15 EP EP14150580.0A patent/EP2719694A1/fr not_active Withdrawn
- 2009-01-15 KR KR20157008524A patent/KR20150042303A/ko not_active Application Discontinuation
- 2009-01-16 CL CL2009000094A patent/CL2009000094A1/es unknown
- 2009-01-16 UY UY031602A patent/UY31602A1/es not_active Application Discontinuation
- 2009-01-17 TW TW103130031A patent/TW201444814A/zh unknown
- 2009-01-17 TW TW103130030A patent/TW201444813A/zh unknown
- 2009-01-17 TW TW098101833A patent/TWI477492B/zh not_active IP Right Cessation
-
2010
- 2010-06-15 NI NI2010001033A patent/NI201001033A/es unknown
- 2010-06-15 NI NI2010001032A patent/NI201001032A/es unknown
- 2010-06-15 NI NI2010001031A patent/NI201001031A/es unknown
- 2010-06-15 NI NI201000103A patent/NI201000103A/es unknown
- 2010-06-17 TN TN2010000284A patent/TN2010000284A1/fr unknown
- 2010-06-28 CR CR11532A patent/CR11532A/es unknown
- 2010-07-01 EC EC2010010324A patent/ECSP10010324A/es unknown
- 2010-07-07 DO DO2010000211A patent/DOP2010000211A/es unknown
- 2010-07-15 IL IL207031A patent/IL207031A/en active IP Right Grant
- 2010-07-15 CO CO10086505A patent/CO6351784A2/es not_active Application Discontinuation
- 2010-07-15 MY MYPI2013003877A patent/MY159362A/en unknown
- 2010-07-16 US US12/837,559 patent/US8378128B2/en active Active
- 2010-07-16 HN HN2010001435A patent/HN2010001435A/es unknown
- 2010-08-13 MA MA33094A patent/MA32086B1/fr unknown
-
2011
- 2011-05-12 HK HK11104670.6A patent/HK1150603A1/xx not_active IP Right Cessation
- 2011-07-14 ZA ZA2011/05206A patent/ZA201105206B/en unknown
-
2013
- 2013-01-15 DO DO2013000016A patent/DOP2013000016A/es unknown
- 2013-02-15 US US13/767,966 patent/US8846959B2/en active Active
- 2013-09-25 DO DO2013000212A patent/DOP2013000212A/es unknown
- 2013-11-04 IL IL229239A patent/IL229239A0/en unknown
- 2013-12-24 JP JP2013265282A patent/JP2014074054A/ja active Pending
-
2014
- 2014-08-06 US US14/453,087 patent/US20140350272A1/en not_active Abandoned
-
2015
- 2015-04-30 JP JP2015093214A patent/JP2015163626A/ja active Pending
-
2016
- 2016-12-05 HR HRP20161655TT patent/HRP20161655T1/hr unknown
- 2016-12-07 CY CY20161101261T patent/CY1119129T1/el unknown
-
2017
- 2017-07-11 US US15/646,375 patent/US10160739B2/en active Active
-
2018
- 2018-11-13 US US16/188,687 patent/US20190144406A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NI201001031A (es) | Formas cristalinas de dimetoxi docetaxel y metodo para preparar el mismo. | |
CL2009000426A1 (es) | Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas | |
NI201200023A (es) | Derivados de 5-fluoropirimidinona | |
GT201300152A (es) | Amidas aminoindanes con una alta actividad fungicida y sus composiciones fitosanitarias | |
CL2012000752A1 (es) | Compuestos derivados de fenilpiri(mi)dinilpirazoles para el control de microorganismos no deseados en la proteccion de plantas y compuestos intermediarios. | |
ECSP12012011A (es) | Ciertas triazolopiridinas y triazolopirazinas, composiciones de estas y sus métodos de empleo | |
CL2012001627A1 (es) | Compuestos derivados de 1,3-tiazol-fenilaminopirimidinas, inhibidores de syk; composición farmacéutica; y su uso para el tratamiento de la artritis reumatoide y cancer. | |
CL2011001333A1 (es) | Compuestos derivados de heterociclos nitrogenados sustituidos, inhibidores de ns5a; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c. | |
CL2013000675A1 (es) | Compuestos derivados de pirazolamida sustituidas, con actividad sobre pge2/ep4; composicion farmaceutica que los comprende; y su uso para el tratamiento de la esclerosis multiple y la artritis reumtoide. | |
CL2013000322A1 (es) | Compuestos derivados de piperidina sustituida; proceso de preparacion; composicion farmaceutica y su uso para producir un efecto antiproliferativo y/o proapoptotico. | |
CL2011000846A1 (es) | Compuestos heterociclicos sustituidos; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c. | |
EA201100037A1 (ru) | Органические соединения | |
CL2011000527A1 (es) | Compuestos derivados de benzofurano; composicion farmaceutica que los comprende;y su uso en el tratamiento de la hepatitis c. | |
CL2008001682A1 (es) | Metodos para el mejoramiento de plantas mediante el uso de informacion directa de secuencias de acidos nucleicos. | |
CL2008002295A1 (es) | Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c. | |
CO7020867A2 (es) | Formulaciones de anticuerpo y metodos | |
BR112013003536A2 (pt) | composição, e utilização de uma composição. | |
CR20120362A (es) | Ciertas triazolopiridinas y triazolopirazinas, composiciones de estas y sus métodos de empleo | |
ATE509931T1 (de) | Azaadamantanester- und carbamatderivate sowie anwendungsverfahren dafür | |
UA106889C2 (uk) | Похідні n1-ацил-5-фторпіримідинону | |
CL2008003095A1 (es) | Procedeimiento de preparacion de dihidrotienopirimidas; uno de los compuestos intermediarios considerados; y el procedimiento de preparacion de dicho compuesto intermediario. | |
LT2013016A (lt) | Aktyvuotos-potencijuotos formos antikūno poveikio padidinimo būdas | |
CL2012001758A1 (es) | Uso de compuestos derivados de 8-hidroxiquinolin-7-carboxamida y sus sales, para el tratamiento y/o prevencion de infecciones fungicas. | |
UY32654A (es) | Compuestos 1-(2-alquil-2,3-dihidro-benzofuran-4-il)-pirrolidin-3-ilaminoacilo | |
CL2008001875A1 (es) | Compuestos derivados de iminooxazol o iminotiazol; composicion que comprende uno de dichos compuestos; procedimiento para controlar plagas; y uso del compuesto o de las composiciones para controlar plagas. |